ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
11 announcements with these filters
JFL Life Sciences Limited announced the re-appointment of its Managing Director, Whole-time Director, and two Independent Directors, each for a five-year term.
Jfl Life Sciences Limited held its 16th Annual General Meeting on August 25, 2026, via video conferencing to transact business as per the notice.
JFL Life Sciences Ltd reported revenue from operations of ₹11.1 Cr (-4.3% YoY) and net profit of ₹1.1 Cr (+57.1% YoY) for Q1 FY27.
JFL Life Sciences Limited will hold a board meeting on 10-Aug-2026 to approve the company's unaudited standalone financial results for the quarter ended June 2026.
JFL Life Sciences Limited issued a notice for its 16th Annual General Meeting, scheduled for August 25, 2026, to consider financial and managerial appointments.
JFL Life Sciences Limited appointed Mr. Jignesh Sharma as Internal Auditor for FY 2026-27. The chartered accountant brings over a decade of bank auditing expertise.
JFL Life Sciences Ltd reported revenue from operations of ₹63.1 Cr (+439.3% YoY) and net profit of ₹1.7 Cr (+1600.0% YoY) for Q4 FY26.
JFL Life Sciences Limited reported a total annual income of ₹131.45 Crore for FY2026. The board also appointed J N GUPTA & Co. as internal auditors.
JFL Life Sciences scheduled a board meeting for May 29, 2026, to approve audited financial results. The trading window remains closed until June 1, 2026.
JFL Life Sciences Limited submitted its Structured Digital Database (SDD) compliance certificate for FY 2025-26. Certified by Prachi Lad & Associates, the report confirms the company captured all 8 required UPSI events, though 5 were delayed. This filing ensures transparency regarding the company's internal controls for preventing insider trading.
JFL Life Sciences Ltd reported net profit of ₹2 Cr (+185.7% YoY) for Q3 FY26.